EPSTEIN BARR VIRUS EBV QUANTITATIVE PCR Test
At DNA Labs UAE, we offer the EPSTEIN BARR VIRUS (EBV) QUANTITATIVE PCR Test at a cost of AED 1200.0. This diagnostic test is used to measure the amount of EBV DNA in a patient’s blood.
Test Components
- Price: 1200.0 AED
- Sample Condition: 3 ml (2 mL min.) whole blood from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
- Report Delivery: Sample Mon / Thu by 9 am; Report Wed / Sat
- Method: Real Time PCR
- Test Type: Infections
- Doctor: Physician
- Test Department: MOLECULAR DIAGNOSTICS
- Pre Test Information: No special preparation required
About the Test
The Epstein Barr Virus (EBV) Quantitative PCR Test is used to detect and measure the amount of EBV DNA in a patient’s blood. EBV is a common virus that infects most people at some point in their lives and is the primary cause of infectious mononucleosis, also known as “mono” or the “kissing disease”.
This test is typically ordered when a healthcare provider suspects an active EBV infection or wants to monitor the viral load in patients with certain medical conditions, such as immunocompromised individuals or those with EBV-associated cancers like Burkitt lymphoma or nasopharyngeal carcinoma.
The test involves collecting a blood sample from the patient and using a technique called polymerase chain reaction (PCR) to amplify and detect the presence of EBV DNA. The PCR test provides quantitative results, indicating the number of viral copies present in the blood sample. This information helps healthcare providers assess the severity of the infection or monitor the effectiveness of treatment.
It is important to note that a positive EBV PCR test does not necessarily mean that the patient has an active EBV infection. The virus can remain dormant in the body for years after the initial infection, so a positive result could indicate a past infection or reactivation of the virus. Interpretation of the test results should be done in conjunction with the patient’s clinical presentation and medical history.
A healthcare provider will be able to provide appropriate guidance and treatment recommendations based on the test results and the patient’s individual circumstances.
| Test Name | EPSTEIN BARR VIRUS EBV QUANTITATIVE PCR Test |
|---|---|
| Components | |
| Price | 1200.0 AED |
| Sample Condition | 3 ml (2 mL min.) whole blood from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. |
| Report Delivery | Sample Mon / Thu by 9 am; Report Wed / Sat |
| Method | Real Time PCR |
| Test type | Infections |
| Doctor | Physician |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | No special preparation required |
| Test Details |
The Epstein Barr Virus (EBV) Quantitative PCR Test is a diagnostic test used to measure the amount of EBV DNA in a patient’s blood. EBV is a common virus that infects most people at some point in their lives and is the primary cause of infectious mononucleosis (also known as “mono” or the “kissing disease”). This test is typically ordered when a healthcare provider suspects an active EBV infection or wants to monitor the viral load in patients with certain medical conditions, such as immunocompromised individuals or those with EBV-associated cancers, like Burkitt lymphoma or nasopharyngeal carcinoma. The test involves collecting a blood sample from the patient and then using a technique called polymerase chain reaction (PCR) to amplify and detect the presence of EBV DNA. The PCR test can provide quantitative results, indicating the number of viral copies present in the blood sample. This information can help healthcare providers assess the severity of the infection or monitor the effectiveness of treatment. It is important to note that a positive EBV PCR test does not necessarily mean that the patient has an active EBV infection. The virus can remain dormant in the body for years after the initial infection, so a positive result could indicate a past infection or reactivation of the virus. Interpretation of the test results should be done in conjunction with the patient’s clinical presentation and medical history. A healthcare provider will be able to provide appropriate guidance and treatment recommendations based on the test results and the patient’s individual circumstances. |
